|
EIF4E3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.337200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.227200E-01 |
| Normal-vs-Stage2 |
3.523800E-01 |
| Normal-vs-Stage3 |
1.100800E-01 |
| Normal-vs-Stage4 |
6.217600E-02 |
| Stage1-vs-Stage2 |
2.715000E-01 |
| Stage1-vs-Stage3 |
5.401800E-02 |
| Stage1-vs-Stage4 |
2.771900E-02 |
| Stage2-vs-Stage3 |
7.842600E-01 |
| Stage2-vs-Stage4 |
5.387400E-01 |
| Stage3-vs-Stage4 |
6.434400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.707800E-01 |
| Normal-vs-AfricanAmerican |
6.681400E-01 |
| Normal-vs-Asian |
4.199000E-01 |
| Caucasian-vs-AfricanAmerican |
8.338800E-01 |
| Caucasian-vs-Asian |
9.320100E-02 |
| AfricanAmerican-vs-Asian |
3.434400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.971150E-01 |
| Normal-vs-Female |
6.270000E-01 |
| Male-vs-Female |
2.785200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.777400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.907000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.032200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.937600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.491970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.240240E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.281700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.186400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.403600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.148800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.736600E-03 |
| Classical-VS-Follicular |
1.389560E-02 |
| Classical-VS-Other |
7.046800E-01 |
| Classical-VS-Normal |
7.619200E-01 |
| Tall-VS-Follicular |
4.457400E-01 |
| Tall-VS-Other |
3.245400E-01 |
| Tall-VS-Normal |
1.928310E-02 |
| Follicular-VS-Other |
6.645200E-01 |
| Follicular-VS-Normal |
7.797800E-02 |
| Other-VS-Normal |
7.254400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.384200E-01 |
| Normal-vs-N1 |
9.075800E-02 |
| N0-vs-N1 |
1.945400E-01 |
|
|
